Article Text
Letters
Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
Statistics from Altmetric.com
Footnotes
-
Funding Funding of the Dutch affiliations of Wyeth Pharmaceuticals, Abbott Pharmaceuticals, Schering-Plough Corporation, Roche Pharmaceuticals, UCB Pharma and Bristol-Myers Squibb enabled the data collection for the DREAM cohort.
-
Competing interests The DREAM registry is funded by several pharmaceutical industries including Roche Pharmaceuticals.
-
Ethics approval The protocol of the DREAM registry has been approved by the responsible medical ethical committee.
-
Provenance and peer review Not commissioned; externally peer reviewed.